Literature DB >> 29515241

The rarity of concomitant genetic alterations in lung cancer.

Laetitia Lambros1, Briac Guibourg1, Glen Le Flahec1, Arnaud Uguen1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29515241     DOI： 10.1038/modpathol.2017.176

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  11 in total

1.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

2.  ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.

Authors:  Antonio Marchetti; Alessia Di Lorito; Maria Vittoria Pace; Manuela Iezzi; Lara Felicioni; Tommaso D'Antuono; Giampaolo Filice; Luigi Guetti; Felice Mucilli; Fiamma Buttitta
Journal:  J Thorac Oncol       Date:  2016-02-22       Impact factor: 15.609

3.  A Rare Case of ROS1 and ALK Double Rearranged Non-Small Cell Lung Cancer.

Authors:  Arnaud Uguen; Ulrike Schick; Gilles Quéré
Journal:  J Thorac Oncol       Date:  2017-06       Impact factor: 15.609

4.  Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

Authors:  A J van der Wekken; R Pelgrim; N 't Hart; N Werner; M F Mastik; L Hendriks; E H F M van der Heijden; M Looijen-Salamon; A J de Langen; J Staal-van den Brekel; S Riemersma; B E van den Borne; E J M Speel; A-M C Dingemans; T J N Hiltermann; A van den Berg; W Timens; E Schuuring; H J M Groen
Journal:  Clin Cancer Res       Date:  2017-02-09       Impact factor: 12.531

Review 5.  Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.

Authors:  Nele Van Der Steen; Yves Mentens; Marc Ramael; Leticia G Leon; Paul Germonpré; Jose Ferri; David R Gandara; Elisa Giovannetti; Godefridus J Peters; Patrick Pauwels; Christian Rolfo
Journal:  Clin Lung Cancer       Date:  2017-07-06       Impact factor: 4.785

6.  MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLC.

Authors:  William Sterlacci; Michael Fiegl; Mathias Gugger; Lukas Bubendorf; Spasenija Savic; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2017-05-20       Impact factor: 4.064

7.  EGFR, KRAS and ROS1 variants coexist in a lung adenocarcinoma patient.

Authors:  Lixia Ju; Mingquan Han; Chao Zhao; Xuefei Li
Journal:  Lung Cancer       Date:  2016-03-15       Impact factor: 5.705

8.  Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?

Authors:  Ibiayi Dagogo-Jack; Alice T Shaw
Journal:  Oncologist       Date:  2016-05-31

Review 9.  Testing for ROS1 in non-small cell lung cancer: a review with recommendations.

Authors:  Lukas Bubendorf; Reinhard Büttner; Fouad Al-Dayel; Manfred Dietel; Göran Elmberger; Keith Kerr; Fernando López-Ríos; Antonio Marchetti; Büge Öz; Patrick Pauwels; Frédérique Penault-Llorca; Giulio Rossi; Aleš Ryška; Erik Thunnissen
Journal:  Virchows Arch       Date:  2016-08-17       Impact factor: 4.064

10.  Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations.

Authors:  Frédéric Dugay; Francisco Llamas-Gutierrez; Marjory Gournay; Sarah Medane; François Mazet; Dan Christian Chiforeanu; Emmanuelle Becker; Régine Lamy; Hervé Léna; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau; Florian Cabillic
Journal:  Oncotarget       Date:  2017-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.